{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:48:02Z","timestamp":1794084482265,"version":"4.8.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K06633"],"award-info":[{"award-number":["23K06633"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["SICORP"],"award-info":[{"award-number":["SICORP"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["P-CREATE"],"award-info":[{"award-number":["P-CREATE"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.1038\/s41416-025-03299-5","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:40:30Z","timestamp":1765863630000},"page":"577-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer"],"prefix":"10.1038","volume":"134","author":[{"given":"Xingxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7797-6453","authenticated-orcid":false,"given":"Keiko","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-2874","authenticated-orcid":false,"given":"Kohei","family":"Kumegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-5964","authenticated-orcid":false,"given":"Reo","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-3235","authenticated-orcid":false,"given":"Shinji","family":"Mii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3666-0556","authenticated-orcid":false,"given":"Yukihiro","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tastunori","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Murofushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Kabasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Futakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"3299_CR1","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"3299_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34081-3","volume":"13","author":"L Shaashua","year":"2022","unstructured":"Shaashua L, Ben-Shmuel A, Pevsner-Fischer M, Friedman G, Levi-Galibov O, Nandakumar S, et al. BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling. Nat Commun. 2022;13:6513.","journal-title":"Nat Commun"},{"key":"3299_CR3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-Induced JAK\/STAT signaling is antagonized by TGF\u03b2 to Shape CAF heterogeneity in pancreatic ductal Adenocarcinoma. Cancer Discov. 2019;9:282\u2013301.","journal-title":"Cancer Discov"},{"key":"3299_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez CX, M\u00fcller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15 myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 2020;10:232\u201353.","journal-title":"Cancer Discov"},{"key":"3299_CR5","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9:1102\u201323.","journal-title":"Cancer Discov"},{"key":"3299_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat Commun. 2023;14:797.","journal-title":"Nat Commun"},{"key":"3299_CR7","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews KM, Chen Y, Darpolor JK, Zheng X, Yang S, Carstens JL, et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer. Cancer Discov. 2022;12:1580\u201397.","journal-title":"Cancer Discov"},{"key":"3299_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/1078-0432.CCR-20-2298","volume":"27","author":"Y Ogawa","year":"2021","unstructured":"Ogawa Y, Masugi Y, Abe T, Yamazaki K, Ueno A, Fujii-Nishimura Y, et al. Three distinct stroma types in human pancreatic cancer identified by image analysis of fibroblast subpopulations and collagen. Clin Cancer Res. 2021;27:107\u201319.","journal-title":"Clin Cancer Res"},{"key":"3299_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25:719\u201334.","journal-title":"Cancer Cell"},{"key":"3299_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","volume":"42","author":"G Mucciolo","year":"2024","unstructured":"Mucciolo G, Araos Henriquez J, Jihad M, Pinto Teles S, Manansala JS, Li W, et al. EGFR-activated myofibroblasts promote metastasis of pancreatic cancer. Cancer Cell. 2024;42:101\u201318 e11.","journal-title":"Cancer Cell"},{"key":"3299_CR11","doi-asserted-by":"crossref","unstructured":"Elsafadi M, Manikandan M, Dawud RA, Alajez NM, Hamam R, Alfayez M, et al. Transgelin is a TGF\u03b2-inducible gene that regulates osteoblastic and adipogenic differentiation of human skeletal stem cells through actin cytoskeleston organization. Cell Death Dis. 2016;7:e2321.","DOI":"10.1038\/cddis.2016.196"},{"key":"3299_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ebiom.2018.10.041","volume":"37","author":"W Zhong","year":"2018","unstructured":"Zhong W, Sun B, Gao W, Qin Y, Zhang H, Huai L, et al. Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction. EBioMedicine. 2018;37:246\u201358.","journal-title":"EBioMedicine"},{"key":"3299_CR13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1161\/CIRCRESAHA.109.213900","volume":"106","author":"J Shen","year":"2010","unstructured":"Shen J, Yang M, Ju D, Jiang H, Zheng JP, Xu Z, et al. Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation. Circ Res. 2010;106:1351\u201362.","journal-title":"Circ Res"},{"key":"3299_CR14","first-page":"12","volume":"2","author":"M Yang","year":"2010","unstructured":"Yang M, Jiang H, Li L. Sm22\u03b1 transcription occurs at the early onset of the cardiovascular system and the intron 1 is dispensable for its transcription in smooth muscle cells during mouse development. Int J Physiol Pathophysiol Pharm. 2010;2:12\u20139.","journal-title":"Int J Physiol Pathophysiol Pharm"},{"key":"3299_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-023-00463-5","volume":"12","author":"C Sun","year":"2023","unstructured":"Sun C, Zhang K, Ni C, Wan J, Duan X, Lou X, et al. Transgelin promotes lung cancer progression via activation of cancer-associated fibroblasts with enhanced IL-6 release. Oncogenesis. 2023;12:18.","journal-title":"Oncogenesis"},{"key":"3299_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-021-02091-6","volume":"40","author":"X Wei","year":"2021","unstructured":"Wei X, Lou H, Zhou D, Jia Y, Li H, Huang Q, et al. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA\/ROCK pathway. J Exp Clin Cancer Res. 2021;40:292.","journal-title":"J Exp Clin Cancer Res"},{"key":"3299_CR17","doi-asserted-by":"crossref","unstructured":"Li H, Song C, Zhang Y, Liu GH, Mi HL, Li YC, et al. Transgelin promotes glioblastoma stem cell hypoxic responses and maintenance through p53 acetylation. Adv Sci. 2024;11:e2305620.","DOI":"10.1002\/advs.202305620"},{"key":"3299_CR18","first-page":"1731","volume":"57","author":"E Rozenblum","year":"1997","unstructured":"Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, et al. Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997;57:1731\u20134.","journal-title":"Cancer Res"},{"key":"3299_CR19","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1101\/gad.1158703","volume":"17","author":"AJ Aguirre","year":"2003","unstructured":"Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, et al. Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003;17:3112\u201326.","journal-title":"Genes Dev"},{"key":"3299_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"3299_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","volume":"53","author":"JM Granja","year":"2021","unstructured":"Granja JM, Corces MR, Pierce SE, Bagdatli ST, Choudhry H, Chang HY, et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat Genet. 2021;53:403\u201311.","journal-title":"Nat Genet"},{"key":"3299_CR22","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-019-0538-0","volume":"51","author":"CP Fulco","year":"2019","unstructured":"Fulco CP, Nasser J, Jones TR, Munson G, Bergman DT, Subramanian V, et al. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat Genet. 2019;51:1664\u20139.","journal-title":"Nat Genet"},{"key":"3299_CR23","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"37","author":"JM Granja","year":"2019","unstructured":"Granja JM, Klemm S, McGinnis LM, Kathiria AS, Mezger A, Corces MR, et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat Biotechnol. 2019;37:1458\u201365.","journal-title":"Nat Biotechnol"},{"key":"3299_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.molcel.2018.06.044","volume":"71","author":"HA Pliner","year":"2018","unstructured":"Pliner HA, Packer JS, McFaline-Figueroa JL, Cusanovich DA, Daza RM, Aghamirzaie D, et al. Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. Mol Cell. 2018;71:858\u201371.e8.","journal-title":"Mol Cell"},{"key":"3299_CR25","doi-asserted-by":"crossref","unstructured":"Muraoka A, Suzuki M, Hamaguchi T, Watanabe S, Iijima K, Murofushi Y, et al. Infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. Sci Transl Med. 2023;15:eadd1531.","DOI":"10.1126\/scitranslmed.add1531"},{"key":"3299_CR26","doi-asserted-by":"crossref","unstructured":"Hosein AN, Huang H, Wang Z, Parmar K, Du W, Huang J, et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight. 2019;5:e129212.","DOI":"10.1101\/539874"},{"key":"3299_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18207-z","volume":"11","author":"Y Schlesinger","year":"2020","unstructured":"Schlesinger Y, Yosefov-Levi O, Kolodkin-Gal D, Granit RZ, Peters L, Kalifa R, et al. Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells\u2019 heterogeneity. Nat Commun. 2020;11:4516.","journal-title":"Nat Commun"},{"key":"3299_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1053\/j.gastro.2020.09.010","volume":"160","author":"K Feldmann","year":"2021","unstructured":"Feldmann K, Maurer C, Peschke K, Teller S, Schuck K, Steiger K, et al. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. Gastroenterology. 2021;160:346\u201361.e24.","journal-title":"Gastroenterology"},{"key":"3299_CR29","doi-asserted-by":"crossref","unstructured":"Liang GY, Oh TG, Hah N, Tiriac H, Shi Y, Truitt ML, et al. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression. Nat Commun. 2023;14:7791.","DOI":"10.1038\/s41467-023-42178-6"},{"key":"3299_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3181\/0707-RM-177","volume":"233","author":"F Jiang","year":"2008","unstructured":"Jiang F, Stefanovic B. Homeobox gene Prx1 is expressed in activated hepatic stellate cells and transactivates collagen \u03b11(I) promoter. Exp Biol Med. 2008;233:286\u201396.","journal-title":"Exp Biol Med"},{"key":"3299_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.bbaexp.2007.06.004","volume":"1769","author":"Y Cheli","year":"2007","unstructured":"Cheli Y, Kanaji S, Jacquelin B, Chang M, Nugent DJ, Kunicki TJ. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2. Biochim Biophys Acta. 2007;1769:546\u201358.","journal-title":"Biochim Biophys Acta"},{"key":"3299_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-593","volume":"13","author":"BW Ferguson","year":"2013","unstructured":"Ferguson BW, Gao X, Zelazowski MJ, Lee J, Jeter CR, Abba MC, et al. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding. BMC Cancer. 2013;13:593.","journal-title":"BMC Cancer"},{"key":"3299_CR33","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1038\/s41388-021-01891-6","volume":"40","author":"J Zhang","year":"2021","unstructured":"Zhang J, Guan W, Xu X, Wang F, Li X, Xu G. A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4\/ZEB1\/miR-142-5p in human ovarian cancer. Oncogene. 2021;40:4906\u201318.","journal-title":"Oncogene"},{"key":"3299_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","volume":"22","author":"OH Oca\u00f1a","year":"2012","unstructured":"Oca\u00f1a OH, C\u00f3rcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 2012;22:709\u201324.","journal-title":"Cancer Cell"},{"key":"3299_CR35","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.ajpath.2012.02.010","volume":"180","author":"B Hu","year":"2012","unstructured":"Hu B, Wu Z, Nakashima T, Phan SH. Mesenchymal-specific deletion of C\/EBP\u03b2 suppresses pulmonary fibrosis. Am J Pathol. 2012;180:2257\u201367.","journal-title":"Am J Pathol"},{"key":"3299_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00372-z","volume":"8","author":"BA Sterken","year":"2022","unstructured":"Sterken BA, Ackermann T, M\u00fcller C, Zuidhof HR, Kortman G, Hernandez-Segura A, et al. C\/EBP\u03b2 isoform-specific regulation of migration and invasion in triple-negative breast cancer cells. npj Breast Cancer. 2022;8:11.","journal-title":"npj Breast Cancer"},{"key":"3299_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05274-6","volume":"9","author":"S-Y Yeo","year":"2018","unstructured":"Yeo S-Y, Lee K-W, Shin D, An S, Cho K-H, Kim S-H. A positive feedback loop bi-stably activates fibroblasts. Nat Commun. 2018;9:3016.","journal-title":"Nat Commun"},{"key":"3299_CR38","doi-asserted-by":"crossref","unstructured":"Chazotte B. Labeling cytoskeletal F-actin with rhodamine phalloidin or fluorescein phalloidin for imaging. Cold Spring Harb Protoc. 2010;2010:pdb.prot4947.","DOI":"10.1101\/pdb.prot4947"},{"key":"3299_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00795-022-00321-0","volume":"55","author":"F Nakayama","year":"2022","unstructured":"Nakayama F, Miyoshi M, Kimoto A, Kawano A, Miyashita K, Kamoshida S, et al. Pancreatic cancer cell-derived exosomes induce epithelial-mesenchymal transition in human pancreatic cancer cells themselves partially via transforming growth factor \u03b21. Med Mol Morphol. 2022;55:227\u201335.","journal-title":"Med Mol Morphol"},{"key":"3299_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2017.08.003","volume":"26","author":"Z Huang","year":"2017","unstructured":"Huang Z, Zhong L, Lee JTH, Zhang J, Wu D, Geng L, et al. The FGF21-CCL11 Axis Mediates Beiging of White Adipose Tissues by Coupling Sympathetic Nervous System to Type 2 Immunity. Cell Metab. 2017;26:493\u2013508.e4.","journal-title":"Cell Metab"},{"key":"3299_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s11658-021-00273-w","volume":"26","author":"S Babazadeh","year":"2021","unstructured":"Babazadeh S, Nassiri SM, Siavashi V, Sahlabadi M, Hajinasrollah M, Zamani-Ahmadmahmudi M. Macrophage polarization by MSC-derived CXCL12 determines tumor growth. Cell Mol Biol Lett. 2021;26:30.","journal-title":"Cell Mol Biol Lett"},{"key":"3299_CR42","doi-asserted-by":"crossref","unstructured":"Tsuji-Tamura K, Morino-Koga S, Suzuki S, Ogawa M. The canonical smooth muscle cell marker TAGLN is present in endothelial cells and is involved in angiogenesis. J Cell Sci. 2021;134:jcs254920.","DOI":"10.1242\/jcs.254920"},{"key":"3299_CR43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ccell.2022.04.011","volume":"40","author":"H Huang","year":"2022","unstructured":"Huang H, Wang Z, Zhang Y, Pradhan RN, Ganguly D, Chandra R, et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell. 2022;40:656\u201373 e7.","journal-title":"Cancer Cell"},{"key":"3299_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ijc.22871","volume":"121","author":"J Kleeff","year":"2007","unstructured":"Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, L\u00f6hr JM, et al. Pancreatic cancer microenvironment. Int J Cancer. 2007;121:699\u2013705.","journal-title":"Int J Cancer"},{"key":"3299_CR45","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.csbj.2020.06.012","volume":"18","author":"S Baek","year":"2020","unstructured":"Baek S, Lee I. Single-cell ATAC sequencing analysis: From data preprocessing to hypothesis generation. Comput Struct Biotechnol J. 2020;18:1429\u201339.","journal-title":"Comput Struct Biotechnol J"},{"key":"3299_CR46","doi-asserted-by":"crossref","unstructured":"Lee KW, Yeo SY, Gong JR, Koo OJ, Sohn I, Lee WY, et al. PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Nat Commun. 2022;13:2793.","DOI":"10.1038\/s41467-022-30484-4"},{"key":"3299_CR47","doi-asserted-by":"publisher","first-page":"655152","DOI":"10.3389\/fcell.2021.655152","volume":"9","author":"X Geng","year":"2021","unstructured":"Geng X, Chen H, Zhao L, Hu J, Yang W, Li G, et al. Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. Front Cell Dev Biol. 2021;9:655152 2296-634X (Print).","journal-title":"Front Cell Dev Biol"},{"key":"3299_CR48","doi-asserted-by":"publisher","first-page":"117590","DOI":"10.1016\/j.jep.2023.117590","volume":"322","author":"J Hu","year":"2024","unstructured":"Hu J, Jiang J, Xu B, Li Y, Wang B, He S, et al. Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules. J Ethnopharmacol. 2024;322:117590.","journal-title":"J Ethnopharmacol"},{"key":"3299_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty AT, Shyer JA, Thai M, Gandham V, Buechler MB, Yang YA, et al. LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature. 2022;611:148\u201354.","journal-title":"Nature"},{"key":"3299_CR50","doi-asserted-by":"publisher","first-page":"612271","DOI":"10.3389\/fimmu.2021.612271","volume":"12","author":"S Liot","year":"2021","unstructured":"Liot S, Balas J, Aubert A, Prigent L, Mercier-Gouy P, Verrier B, et al. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins. Front Immunol. 2021;12:612271.","journal-title":"Front Immunol"},{"key":"3299_CR51","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0119","volume":"11","author":"YJ Zhang","year":"2021","unstructured":"Zhang YJ, Recouvreux MV, Jung M, Galenkamp KMO, Li YB, Zagnitko O, et al. Macropinocytosis in cancer-associated fibroblasts is dependent on CaMKK2\/ARHGEF2 signaling and functions to support tumor and stromal cell fitness. Cancer Discov. 2021;11:1808\u201325.","journal-title":"Cancer Discov"},{"key":"3299_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100160","volume":"63","author":"D Lucero","year":"2022","unstructured":"Lucero D, Dikilitas O, Mendelson MM, Aligabi Z, Islam P, Neufeld EB, et al. Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen. J Lipid Res. 2022;63:100160.","journal-title":"J Lipid Res"},{"key":"3299_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s42003-024-06087-8","volume":"7","author":"K Boelaars","year":"2024","unstructured":"Boelaars K, Rodriguez E, Huinen ZR, Liu C, Wang D, Springer BO, et al. Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions. Commun Biol. 2024;7:430.","journal-title":"Commun Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03299-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:03:32Z","timestamp":1769774612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03299-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,20]]}},"alternative-id":["3299"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03299-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research protocol was approved by the Institutional Review Board of Nagoya University of Graduate School of Medicine (2017-0127). An animal study was performed under protocols approved by the Institutional Animal Care and Use Committee of Nagoya University of Graduate School of Medicine (M240289-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}